References
- Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–85.
- Patel V, Horn EJ, Lobosco SJ, et al. Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists. J Am Acad Dermatol. 2008;58:964–9.
- Murphy G, Reich K. In touch with psoriasis: topical treatments and current guidelines. J Eur Acad Dermatol Venereol. 2011;25:3–8.
- Svendsen MT, Jeyabalan J, Andersen KE, et al. Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review. J Dermatolog Treat. 2016. [Epub ahead of print]; [1–10]. doi: 10.1080/09546634.2016.1254331
- Svendsen MT, Andersen F, Hansen J, et al. Medical adherence to topical corticosteroid preparations prescribed for psoriasis: a systematic review. J Dermatolog Treat. 2017;28:32–39.
- Thorneloe RJ, Bundy C, Griffiths CEM, et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013;168:20–31.
- Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27–33.
- Storm A, Benfeldt E, Andersen SE, Serup J. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol. 2008;59:975–80.
- Urquhart J. The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response. Br J Clin Pharmacol. 2002;54:212–20.
- Haase J, Farris KB, Dorsch MP. Mobile applications to improve medication adherence. Telemedicine J E Health. 2017; 23/2:1530–5627.
- Tudor Car L, Riboli-Sasco EF, Marcano Belisario JS, et al. Mobile learning for delivering health professional education. Cochrane Libr. 2015;(9):CD011861.
- Ventola CL. Mobile devices and apps for health care professionals: uses and benefits. P T. 2014;39:356–64.
- Buijink AW, Visser BJ, Marshall L. Medical apps for smartphones: lack of evidence undermines quality and safety. Evid Based Med. 2013;18:90–2.
- Boogerd EA, Arts T, Engelen LJ, van de Belt TH. “What Is eHealth”: time for an update? JMIR Res Protoc. 2015;4:e29.
- WHO. Atlas of eHealth country profiles: the use of eHealth in support of universal health coverage: based on the findings of the third global survey on eHealth 2015. Geneva, Switzerland: World Health Organization, 2016.
- Chambers CJ, Parsi KK, Schupp C, Armstrong AW. Patient-centered online management of psoriasis: a randomized controlled equivalency trial. J Am Acad Dermatol. 2012;66:948–53.
- Mercer JM. An array of mobile apps for dermatologists. J Cutan Med Surg. 2014;18:295–7.
- Balato N, Megna M, Di Costanzo L, et al. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol. 2013;168:201–5.
- Silva BM, Rodrigues JJ, de la Torre Díez I, et al. Mobile-health: a review of current state in 2015. J Biomed Inform. 2015;56:265–72.
- Devaux S, Castela A, Archier E, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26:61–7.
- Rahman M, Alam K, Ahmad MZ, et al. Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets. 2012;12:287–302.
- Mason AR, Mason J, Cork M, et al. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. 2013;(3):Cd005028.
- Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–34.
- Babineau J. Product review: covidence (systematic review software). JCHLA/JABSC. 2014;35:68–71.
- Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:1.
- Alinia H, Tuchayi SM, Smith JA, et al. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. Br J Dermatol. 2017;176:759–764.
- Vrijens B, Urquhart J, White D. Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev Clin Pharmacol. 2014;7:633–44.
- Greenlaw SM, Yentzer BA, O'Neill JL, et al. Assessing adherence to dermatology treatments: a review of self-report and electronic measures. Skin Res Technol. 2010;16:253–8.
- Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:Cd000011.
- Abroms LC, Westmaas JL, Bontemps-Jones J, et al. A content analysis of popular smartphone apps for smoking cessation. Am J Prev Med. 2013;45:732–6.
- Dayer L, Heldenbrand S, Anderson P, et al. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc. 2013;53:172–81.
- Forum. Health apps: regulation and quality control. Acad Med Sci. 2015:1–32.
- Carroll NR. Mobile medical app regulation: preventing a pandemic of ‘Mobilechondriacs’. St Louis J Health Law Policy. 2014;7:415.
- Svendsen MT, Andersen KE, Andersen F, et al. Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids. Psoriasis Targets Ther. 2016;6:113–19.
- Mulvaney SA, Anders S, Smith AK, et al. A pilot test of a tailored mobile and web-based diabetes messaging system for adolescents. J Telemed Telecare. 2012;18:115–8.
- Petrie KJ, Perry K, Broadbent E, Weinman J. A text message programme designed to modify patients' illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol. 2012;17:74–84.
- Nolan BV, Feldman SR. Dermatologic medication adherence. Dermatol Clin. 2009;27:113–20.
- Feldman SR. Using Hawthorne effects to improve adherence in clinical practice: Lessons from clinical trials. JAMA. 2013;149:490–1.